Athanor Capital’s Medifast MED Stock Holding History

Athanor Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,141	Closed	-$242K	–	633
2021 Q1	$242K	Sell	1,141 -673	-37%	-$161K	0.01%	642
2020 Q4	$356K	Buy	+1,814	New	+$321K	0.01%	539

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Athanor Capital's MED Position: Q2 2021 in Review

Athanor Capital sold out of Medifast (MED) in Q2 2021, closing a stake of 1,141 shares — an estimated $242K sold.

Athanor Capital first reported a position in MED in Q4 2020 and held it in 2 quarters. The position peaked at $356K in Q4 2020. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

Athanor Capital reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
Athanor Capital sold 1,141 Medifast shares in Q2 2021, an estimated $242K.
Athanor Capital first reported a position in Medifast in Q4 2020 and held it in 2 quarters.
Athanor Capital's Medifast position peaked at $356K in Q4 2020.
301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.